Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,172,461
+$218,260 QoQ
Shares Held
340,028
+15.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#90
of 639 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sanctuary Advisors, LLC holds $25,944,542 across 16 Drug Manufacturers - Specialty & Generic names. HLN ranks #4 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
272,749 | $4,331,254 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
105,645 | $3,662,712 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
18,927 | $3,189,956 | |
| 4 | HLN |
Haleon plc
This page
|
340,028 | $3,172,461 | |
| 5 | ZTS |
Zoetis Inc.
|
43,902 | $3,154,797 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
74,865 | $2,536,426 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
13,756 | $1,138,721 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
1,695 | $918,401 |
All Filings in HLN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,172,461 | 340,028 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,954,201 | 295,125 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $2,948,369 | 291,629 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,997,224 | 222,656 | Shares | Sole | 2026-01-06 | |
| 2025-06-30 | $2,325,327 | 224,236 | Shares | Sole | 2026-01-06 | |
| 2025-03-31 | $2,291,130 | 222,656 | Shares | Sole | 2026-01-06 | |
| 2024-12-31 | $2,288,445 | 239,879 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $2,595,379 | 245,310 | Shares | Sole | 2024-11-25 | |
| 2024-06-30 | $1,620,991 | 196,246 | Shares | Sole | 2024-09-05 | |
| No filing history on record for this holder in this stock. | ||||||